![News - CHMP Recommends Additional Authorisation Modification of Comirnaty (BioNTech/Pfizer) As a Bivalent Vaccine Adapted to Omicron BA.4/BA.5 for Booster Vaccinations - Paul-Ehrlich-Institut News - CHMP Recommends Additional Authorisation Modification of Comirnaty (BioNTech/Pfizer) As a Bivalent Vaccine Adapted to Omicron BA.4/BA.5 for Booster Vaccinations - Paul-Ehrlich-Institut](https://www.pei.de/SharedDocs/Bilder/EN/newsroom-en/hp-news-pm/omicron-ba5-chmp.jpg?__blob=thumbnail&v=6)
News - CHMP Recommends Additional Authorisation Modification of Comirnaty (BioNTech/Pfizer) As a Bivalent Vaccine Adapted to Omicron BA.4/BA.5 for Booster Vaccinations - Paul-Ehrlich-Institut
![Additional COVID-19 Boosters Cleared for Older Adults, Immunocompromised People | Chicago News | WTTW Additional COVID-19 Boosters Cleared for Older Adults, Immunocompromised People | Chicago News | WTTW](https://news.wttw.com/sites/default/files/field/image/hypatia-h_58a813750f4577905eddc887fd65e32c-h_d8f2bc5d016b272c930190a4fc42c49c.jpg)
Additional COVID-19 Boosters Cleared for Older Adults, Immunocompromised People | Chicago News | WTTW
![Vaccino anti-Covid, richiamo con bivalente per i fragili dai 5 agli 11 anni - Salute, sport e buona vita - Regione Puglia Vaccino anti-Covid, richiamo con bivalente per i fragili dai 5 agli 11 anni - Salute, sport e buona vita - Regione Puglia](https://www.regione.puglia.it/documents/56205/4225137/dosi+vaccino.jpg/b40cd015-007e-d2e6-9519-2ddd13eeed1a?t=1673955186191)
Vaccino anti-Covid, richiamo con bivalente per i fragili dai 5 agli 11 anni - Salute, sport e buona vita - Regione Puglia
Dal 30 settembre è possibile prenotare la quarta dose vaccinale per gli over 12. Arrivato un primo quantitativo del nuovo vaccino bivalente aggiornato alla variante4 BA 4-5 disponibile dal 1° ottobre
![News - CHMP Recommends Authorisation of Comirnaty Variant (BioNTech/Pfizer) Adapted to Omicron BA.4/BA.5 As Booster Vaccination for Children Aged 5 to 11 Years - Paul-Ehrlich-Institut News - CHMP Recommends Authorisation of Comirnaty Variant (BioNTech/Pfizer) Adapted to Omicron BA.4/BA.5 As Booster Vaccination for Children Aged 5 to 11 Years - Paul-Ehrlich-Institut](https://www.pei.de/SharedDocs/Bilder/EN/newsroom-en/hp-news-pm/comirnaty-booster-opinion-adolescents.jpg?__blob=thumbnail&v=4)
News - CHMP Recommends Authorisation of Comirnaty Variant (BioNTech/Pfizer) Adapted to Omicron BA.4/BA.5 As Booster Vaccination for Children Aged 5 to 11 Years - Paul-Ehrlich-Institut
![Covid: Aifa approva il vaccino bivalente Comirnaty sviluppato contro Omicron 4-5 | Sanità24 - Il Sole 24 Ore Covid: Aifa approva il vaccino bivalente Comirnaty sviluppato contro Omicron 4-5 | Sanità24 - Il Sole 24 Ore](https://www.sanita24.ilsole24ore.com/images2014/Editrice/ILSOLE24ORE/QUOTIDIANO_SANITA/2022/09/15/Quotidiano%20Sanita/ImmaginiWeb/Clipboard-0016.png)
Covid: Aifa approva il vaccino bivalente Comirnaty sviluppato contro Omicron 4-5 | Sanità24 - Il Sole 24 Ore
![Are you staying up to date on your COVID-19 vaccinations?' asks Peterborough's medical officer of health | kawarthaNOW Are you staying up to date on your COVID-19 vaccinations?' asks Peterborough's medical officer of health | kawarthaNOW](https://kawarthanow.com/wp-content/uploads/2022/10/pfizer-bivalent-vaccine.jpg)